tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2022-12-3-43-48tumors-1010Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCLINICAL NOTESКлинический случай предоперационной лучевой терапии с последующей операцией у больного гигантской первичной G1 забрюшинной липосаркомойCase report of preoperative radiotherapy followed by surgery in patient with giant primary retroperitoneal G1 liposarcomaБартЮ. И.Bart Yu.  I.

Юлия И. Барт, врач-радиотерапевт

Москва

Yulia I. Bart, radiation therapist 

Moscow

bart.yulia@yandex.ruГлибичукД. А.Glibichuk D.  A.

Дмитрий А. Глибичук, аспирант кафедры онкологии

Москва

Dmitry A. Glibichuk, post-graduate student, Department of Oncology 

Moscow

dr.glibichuk@gmail.comАбдулаеваР. Ш.AbdulaevaR.  Sh.

Рукият Ш. Абдулаева, ординатор 2-го года кафедры онкологии и лучевой терапии

Москва

Rukiyat Sh. Abdulaeva, second-year resident, Department of Oncology and Radiotherapy 

Moscow

ruutlevi@gmail.comАвдюхинИ. Г.Avdyukhin I.  G.

Иван Г. Авдюхин, аспирант 1-го года хирургического отделения № 6 абдоминальной онкологии

Москва

Ivan G. Avdyukhin, first-year postgraduate student, Department of Abdominal Surgical Oncology No. 6 

Moscow

ivan.avdyukhin@gmail.comКалининА. Е.Kalinin А.  Е.

Алексей Е. Калинин, к. м. н., старший научный сотрудник, и. о. заведующего хирургического отделения № 6 абдоминальной онкологии

Москва

Alexey E. Kalinin, MD, PhD, Senior Researcher, Acting Head of the Department of Abdominal Surgical Oncology No. 6 

Moscow

main2001@inbox.ruЧерныхМ. В.ChernykhM.  V.

Марина В. Черных, к. м. н., заведующий отделением радиотерапии, заместитель директора по лечебной работе НИИ КиЭР; доцент кафедры онкологии, радиотерапии и пластической хирургии

Москва

Marina V. Chernykh, MD, PhD, Head of the Radiotherapy Department, Deputy Medical Director; Associate Professor of the Department of Oncology, Radiotherapy and Plastic Surgery

Moscow

dr.chernich@mail.ruФГБУ «НМИЦ онкологии им. Н.Н. Блохина Минздрава РоссииРоссияN. N. Blokhin National Research Center of OncologyRussian FederationФГБУ «Российский университет дружбы народов» Минздрава РоссииРоссияPeoples’ Friendship University of RussiaRussian FederationФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава РоссииРоссияPirogov Russian National Research Medical UniversityRussian FederationФГБУ «НМИЦ онкологии им. Н.Н. Блохина Минздрава России; ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава РоссииРоссияN. N. Blokhin National Research Center of Oncology; Sechenov First Moscow State Medical UniversityRussian Federation2022011220221234348Copyright © Барт Ю.И., Глибичук Д.А., Абдулаева Р.Ш., Авдюхин И.Г., Калинин А.Е., Черных М.В., 20222022Барт Ю.И., Глибичук Д.А., Абдулаева Р.Ш., Авдюхин И.Г., Калинин А.Е., Черных М.В.Bart  Y. ., Glibichuk  D.A., Abdulaeva R.S., Avdyukhin  I.G., Kalinin  А.Е., Chernykh M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/1010

Несмотря на развитие современных технологий хирургических методов лечения, основной проблемой лечения забрюшинных липосарком является их местнорецидивирующий характер. В настоящее время ведущим методом лечения этого заболевания является хирургический. Перед мировым онкологическим сообществом стоит глобальная цель — разработка новых подходов в комбинированном лечении больных забрюшинными липосаркомами, что позволит снизить частоту рецидивов в послеоперационном периоде и повысить общую выживаемость пациентов с данной нозологией. В представленной статье представлены данные мировой литературы по методам лечения больных с забрюшинными липосаркомами, а также демонстрируется клинический случай лечения пациента с указанной нозологией в НМИЦ онкологии им. Н.Н. Блохина.

Despite the development of contemporary surgical management of retroperitoneal liposarcomas, local recurrence remains the major challenge in the treatment of these tumors. Currently, surgery is the main treatment option for liposarcoma. The international cancer community faces a global goal — the development of new combined treatment options for the treatment of retroperitoneal liposarcoma to reduce the postoperative recurrence rate and increase the overall survival. This article presents the world literature data on the treatment of retroperitoneal liposarcomas and demonstrates a case report describing treatment of a patient with this disease in the N. N. Blokhin NMRC of Oncology.

забрюшинные липосаркомынеоадъювантная лучевая терапиябезрецидивная выживаемостьretroperitoneal liposarcomasneoadjuvant radiotherapydisease-free survivalReferencesIshii, K., Yokoyama, Y., Nishida, Y., Koike, H., Yamada, S., Kodera, Y., Sassa, N., Gotoh, M., & Nagino, M. (2020). Characteristics of primary and repeated recurrent retroperitoneal liposarcoma : Outcomes after aggressive surgeries at a single institution. Japanese Journal of Clinical Oncology, 50 (12), 1412–1418.Ishii, K., Yokoyama, Y., Nishida, Y., Koike, H., Yamada, S., Kodera, Y., Sassa, N., Gotoh, M., & Nagino, M. (2020). Characteristics of primary and repeated recurrent retroperitoneal liposarcoma : Outcomes after aggressive surgeries at a single institution. Japanese Journal of Clinical Oncology, 50 (12), 1412–1418.Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal Soft-Tissue Sarcoma Analysis of 500 Patients Treated and Followed at a Single Institution. Ann Surg. 1998.Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal Soft-Tissue Sarcoma Analysis of 500 Patients Treated and Followed at a Single Institution. Ann Surg. 1998.Miao, C.-L., Zhang, L.-L., Tseng, W. W., Qiu, F.-B., Lu, W.-Q., Dai, Y.-G., Rao, X.-S., Li, W.-J., Zhang, G.-K., Chen, J., Liu, W.-Q., Chen, X.-B., Xiao, M.-M., Cha, L.-C., Wang, J.-Y., Ren, Y.-B., Yang, H.-Y., & Luo, C.-H. (2022). A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma : a comparative multi-institutional study. Annals of Translational Medicine, 10 (14), 785–785.Miao, C.-L., Zhang, L.-L., Tseng, W. W., Qiu, F.-B., Lu, W.-Q., Dai, Y.-G., Rao, X.-S., Li, W.-J., Zhang, G.-K., Chen, J., Liu, W.-Q., Chen, X.-B., Xiao, M.-M., Cha, L.-C., Wang, J.-Y., Ren, Y.-B., Yang, H.-Y., & Luo, C.-H. (2022). A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma : a comparative multi-institutional study. Annals of Translational Medicine, 10 (14), 785–785.Gronchi A, Miceli R, Allard MA, Callegaro D, le Péchoux C, Fiore M, et al. Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma : Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection. Ann Surg Oncol. Springer New York LLC ; 2015 ; 22 : 1447–54.Gronchi A, Miceli R, Allard MA, Callegaro D, le Péchoux C, Fiore M, et al. Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma : Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection. Ann Surg Oncol. Springer New York LLC ; 2015 ; 22 : 1447–54.Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001) : an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. Lancet Publishing Group ; 2017 ; 18 : 812–22.Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001) : an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. Lancet Publishing Group ; 2017 ; 18 : 812–22.Gronchi A, Palmerini E, Quagliuolo V, Javier Broto M, Lopez Pousa A, et al. Neoadjuvant Chemotherapy in HighRisk Soft Tissue Sarcomas : Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups [Internet]. J Clin Oncol. 2020. Available from: www.sarculator.comGronchi A, Palmerini E, Quagliuolo V, Javier Broto M, Lopez Pousa A, et al. Neoadjuvant Chemotherapy in HighRisk Soft Tissue Sarcomas : Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups [Internet]. J Clin Oncol. 2020. Available from: www.sarculator.comBallo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, et al. Retroperitoneal soft tissue sarcoma : An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 ; 67 : 158–63.Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, et al. Retroperitoneal soft tissue sarcoma : An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 ; 67 : 158–63.Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, et al. Combined modality management of retroperitoneal sarcomas : A single-institution series of 121 patients. Int J Radiat Oncol Biol Phys. Elsevier Inc. ; 2015 ; 93 : 158–65.Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, et al. Combined modality management of retroperitoneal sarcomas : A single-institution series of 121 patients. Int J Radiat Oncol Biol Phys. Elsevier Inc. ; 2015 ; 93 : 158–65.Zlotecki RA, Katz TS, Morris CG, Scott Lind D, Hochwald SN. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma : The University of Florida experience. American Journal of Clinical Oncology : Cancer Clinical Trials. 2005 ; 28 : 310–6.Zlotecki RA, Katz TS, Morris CG, Scott Lind D, Hochwald SN. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma : The University of Florida experience. American Journal of Clinical Oncology : Cancer Clinical Trials. 2005 ; 28 : 310–6.DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. Elsevier Inc ; 2017 ; 2 : 85–93.DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. Elsevier Inc ; 2017 ; 2 : 85–93.Pawlik TM, Pisters PWT, Mikula L, Feig BW, Hunt KK, Cormier JN, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006 ; 13 : 508–17.Pawlik TM, Pisters PWT, Mikula L, Feig BW, Hunt KK, Cormier JN, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006 ; 13 : 508–17.Bonvalot S, Gronchi A, le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092 : STRASS) : a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. Lancet Publishing Group ; 2020 ; 21 : 1366–77.Bonvalot S, Gronchi A, le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092 : STRASS) : a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. Lancet Publishing Group ; 2020 ; 21 : 1366–77.

The authors declare that there are no conflicts of interest present.